OLK

Olink Holding AB (publ) American Depositary Shares

Delisted

OLK was delisted on the 9th of July, 2024.

 

About: Olink Holding AB has a proprietary and patented Proximity Extension Assay technology, which enables researchers to use one platform for discovery to clinical trials to diagnostic applications utilizing the established infrastructure of labs and installed instrumentation. It has two segments including Kit and Services. It derives revenues from Sweden, the United States which also generates key revenue, China, EMEA (Excluding Sweden) Japan, and other regions.

Employees: 707

Financial journalist opinion

Neutral
Business Wire
4 months ago
Olink® Reveal Seamlessly Connects Genomics and Proteomics, Empowering Researchers to Uncover the Dynamic Mechanisms Underlying Biology
UPPSALA, Sweden--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the introduction of Olink® Reveal, setting a new standard for affordable, high-plex proteomics that enables researchers to identify circulating biomarkers for a range of applications with reduced cost and set up requirements. Olink Reveal represents a powerful new tool for proteomics research, measuring ~1,000 carefully selected human proteins to broadly screen the proteome while als.
Olink® Reveal Seamlessly Connects Genomics and Proteomics, Empowering Researchers to Uncover the Dynamic Mechanisms Underlying Biology
Neutral
GlobeNewsWire
10 months ago
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
This is a translation of the Swedish original. In case of any discrepancies between this translation and the  Swedish original, the latter shall prevail.
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
Neutral
Business Wire
10 months ago
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed its acquisition of Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), a leading provider of next-generation proteomics solutions. The transaction values Olink at approximately $3.1 billion, net of $96 million of acquired cash. Olink will become part of Thermo Fisher's Life Sciences Solutions segment. “We are excited to welcome Oli.
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
Positive
Zacks Investment Research
10 months ago
Olink's (OLK) Acquisition by Thermo Fisher Gets UK CMA Nod
Olink's (OLK) buyout by Thermo Fisher gets CMA's approval, signaling regulatory confidence in the merger's compliance with competition laws.
Olink's (OLK) Acquisition by Thermo Fisher Gets UK CMA Nod
Neutral
GlobeNewsWire
11 months ago
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
UPPSALA, Sweden, July 08, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced that the UK Competition and Markets Authority (the “CMA”) has unconditionally approved the previously announced tender offer (the “Offer”) by Orion Acquisition AB (the “Buyer”), a wholly owned subsidiary of Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher” or “Parent”), for all outstanding Common Shares and American Depositary Shares (together, the “Shares”) of Olink for $26.00 per Share.
Olink Announces Receipt of CMA Clearance for Proposed Acquisition by Thermo Fisher
Positive
Reuters
11 months ago
UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal
UK's competition regulator said on Monday it has cleared U.S. medical equipment maker Thermo Fisher Scientific's $3.1 billion deal to buy Swedish biotech firm Olink Holding AB.
UK's competition regulator clears $3.1 bln Thermo Fisher Scientific-Olink deal
Neutral
GlobeNewsWire
11 months ago
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
UPPSALA, Sweden, July 05, 2024 (GLOBE NEWSWIRE) -- At the Extra General Meeting (the “EGM”) of Olink Holding AB (publ), reg. no 559189-7755, (the “Company”), the EGM adopted, inter alia, the following resolutions. For more detailed information regarding the contents of the resolutions, please refer to the notice to the EGM and the complete proposals, which have previously been published and are available on the Company's website, www.olink.com.
Report from the Extra General Meeting of Olink Holding AB (publ) on 5 July 2024
Neutral
GlobeNewsWire
11 months ago
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
UPPSALA, Sweden, July 03, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK), a global leader in proteomics, introduces its inaugural network of Olink® Certified Service Providers. The group of Olink Certified Service Providers represent leading contract research organizations (CROs) and service labs around the world.
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
Neutral
GlobeNewsWire
11 months ago
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
This is a translation of the Swedish original. In case of any discrepancies between this translation and the Swedish original, the latter shall prevail.
Notice to attend the Extra General Meeting of Olink Holding AB (publ)
Neutral
GlobeNewsWire
1 year ago
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a detailed view of the immune system for in-depth monitoring of inflammation and immune response in clinical research.
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
Charts implemented using Lightweight Charts™